| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $800,684 ) |
| | 2023 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | 2301NEILSG | ILSG-2023 | 0 | 1 | ACL | 11/1/2022 | $71,469 |
| | 2023 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R21AI173990 | Coxiella secreted proteins mediating inter-organelle membrane contact sites | 000 | 1 | NIH | 11/4/2022 | $230,250 |
| | 2023 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 985805 Nebraska Medical Ctr | Omaha | NE | 68198-5805 | DOUGLAS | USA | U3N45394 | Health and Public Safety Workforce Resiliency Training Program | 00 | 2 | HRSA | 11/15/2022 | $698,243 |
| | 2023 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | U01MH120155 | Dose-Response Relationship and Pharmacokinetics of Intranasal Oxytocin on Neural Impact in Youths with High Levels of Irritability | 001 | 3 | NIH | 10/27/2022 | $0 |
| | 2023 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01MH121402 | HIV Theranostic | 000 | 4 | NIH | 10/18/2022 | $0 |
| | 2023 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | U0117261 | Partnership for Urban MCH Leadership Community | 03 | 12 | HRSA | 10/18/2022 | $0 |
| | 2023 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | M0131368 | Behavioral Health Workforce Education and Training (BHWET) Program | 01 | 6 | HRSA | 10/5/2022 | $0 |
| | 2023 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | U54GM115458 | Great Plains IDeA-CTR | 000 | 7 | NIH | 11/21/2022 | $0 |
| | 2023 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | T5246757 | Public Health Scholarship Program | 01 | 1 | HRSA | 10/12/2022 | $0 |
| | 2023 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01HL164306 | Diastolic Heart Failure in HIV-1 infection | 000 | 1 | NIH | 11/21/2022 | $489 |
| | 2023 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R21AI164376 | Performance of the pooled testing strategy for detecting and estimating the prevalence and intensity of Schistosoma haematobium infection at a population level | 000 | 1 | NIH | 10/17/2022 | $0 |
| | 2023 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R21DA054818 | Racial disparities in biomarkers, tobacco cessation, and smoking relapse in association with electronic cigarette use | 000 | 2 | NIH | 10/17/2022 | $0 |
| | 2023 | 2021 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | U01MH120155 | Dose-Response Relationship and Pharmacokinetics of Intranasal Oxytocin on Neural Impact in Youths with High Levels of Irritability | 000 | 2 | NIH | 10/25/2022 | $0 |
| | 2023 | 2021 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | U01AI130841 | Uncovering pathogenic anti-bacterial defense mechanisms to identify novel targets for prevention of T1D | 000 | 5 | NIH | 10/31/2022 | $0 |
| | 2023 | 2021 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | U01AI130841 | Uncovering pathogenic anti-bacterial defense mechanisms to identify novel targets for prevention of T1D | 000 | 5 | NIH | 10/31/2022 | $0 |
| | 2023 | 2021 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01GM100156 | Mechanistic studies of stalled DNA replication fork rescue | 000 | 9 | NIH | 10/28/2022 | $0 |
| | 2023 | 2021 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01MH067234 | Effects Of Environmental Challenges On Genetically Modified Interneuronal Subpopulations | 000 | 15 | NIH | 11/15/2022 | -$83,673 |
| | 2023 | 2020 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R03AG060095 | An Expanded Framework to Measure Cognitive Function in Older Adults Undergoing Hematopoietic Cell Transplantation | 000 | 2 | NIH | 10/27/2022 | $0 |
| | 2023 | 2020 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01AR070242 | Cell biological mechanisms that regulate development of cartilage architecture | 000 | 5 | NIH | 11/16/2022 | $0 |
| | 2023 | 2020 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | P30CA036727 | COVID-19 Antigen Team for Immunotherapy and Monitoring Patient Immune Response | 000 | 33 | NIH | 10/11/2022 | -$885 |
| | 2023 | 2019 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | 1901NEILSG | ILSG-2019 | 2 | 1 | ACL | 11/17/2022 | -$4,612 |
| | 2023 | 2018 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | 1801NEILSG | FY18 ILSG_B | 4 | 1 | ACL | 11/17/2022 | -$81,122 |
| | 2023 | 2017 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R15NR017522 | Engaging Rural Men with Mobile Technologies for Weight Loss. A Randomized Controlled Trial. | 000 | 1 | NIH | 10/1/2022 | -$2,261 |
| | 2023 | 2017 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | 17G1NEILSG | FY17 ILSG_B | 4 | 1 | ACL | 11/17/2022 | -$27,213 |
|
| Issue Date FY: 2022 ( Subtotal = $120,448,757 ) (Continued on the next page) |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | F30DA048713 | The impact of chronic cannabis use on neuromagnetic activity in persons living with HIV | 000 | 4 | NIH | 6/7/2022 | $45,732 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01GM131092 | Mechanisms by which phosphorylation and protein partners regulate Cx45 | 000 | 4 | NIH | 6/24/2022 | $413,290 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01AA026723 | Impaired phospholipid methylation results in decreased lipid droplet lipolysis: Role in hepatic steatosis | 000 | 5 | NIH | 3/30/2022 | $314,573 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 Nebraska Medical Center | OMAHA | NE | 68198-7835 | DOUGLAS | USA | U3N45394 | Health and Public Safety Workforce Resiliency Training Program | 00 | 1 | HRSA | 12/29/2021 | $1,058,124 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | K23AI134307 | Clinical Pharmacology of Efavirenz Combined with High Dose Rifapentine | 000 | 5 | NIH | 3/29/2022 | $162,603 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | T32NS105594 | Neuroimmunology of Disease Training Program | 000 | 5 | NIH | 5/12/2022 | $85,535 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | T32NS105594 | Neuroimmunology of Disease Training Program | 001 | 5 | NIH | 5/23/2022 | -$4 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01NS109381 | The Role of Astrocytes in the Fragile X Pathogenesis | 001 | 4 | NIH | 6/22/2022 | $45,726 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01NS109381 | The Role of Astrocytes in the Fragile X Pathogenesis | 000 | 4 | NIH | 12/20/2021 | $411,539 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01NS107369 | Immune mechanisms that promote S. aureus persistence during craniotomy-associated biofilm infection | 000 | 5 | NIH | 3/29/2022 | $412,212 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01AR073225 | 3D Bioprinting of Biomimetic Constructs for Rotator Cuff Augmentation | 000 | 5 | NIH | 8/11/2022 | $404,564 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | P30GM127200 | Nebraska Center for Nanomedicine | 000 | 5 | NIH | 8/24/2022 | $1,143,750 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R25CA221777 | Ignite-Engage-Sustain: a comprehensive approach to motivate, involve, educate, and mentor Native American students and their communities in cancer prevention, treatment, and research | 000 | 5 | NIH | 2/10/2022 | $457,740 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01CA233037 | The novel role of microtubule regulators in the DNA damage response | 003 | 2 | NIH | 5/26/2022 | $3,635 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01CA233037 | The novel role of microtubule regulators in the DNA damage response | 002 | 2 | NIH | 5/23/2022 | $26,803 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01CA233037 | The novel role of microtubule regulators in the DNA damage response | 001 | 2 | NIH | 3/11/2022 | $40,901 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01CA233037 | The novel role of microtubule regulators in the DNA damage response | 000 | 2 | NIH | 1/11/2022 | $301,529 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01CA205025 | Managing Fatigue Using Virtual Reality for Post-Operative Lung Cancer Patients | 000 | 6 | NIH | 9/6/2022 | $448,440 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01CA228524 | Targeting CXCR2 axis in Pancreatic Cancer | 001 | 5 | NIH | 5/24/2022 | $32,206 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01CA228524 | Targeting CXCR2 axis in Pancreatic Cancer | 000 | 5 | NIH | 2/11/2022 | $362,302 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | UG1OD024953 | The Nebraska Pediatric Clinic Trials Unit | 001 | 5 | NIH | 8/29/2022 | $408,819 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01GM123081 | Nanofiber-based Delivery of Combined Immune-modulating Compounds to Minimize Infection and Enhance Wound Healing | 001 | 6 | NIH | 6/27/2022 | $322,546 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | U01CA210240 | Pancreatic Cancer Detection Consortium | 002 | 6 | NIH | 9/7/2022 | $857,987 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R50CA211462 | Critical Resources Provided by UNMC RAP Biorepository Stimulate Cancer Research | 002 | 7 | NIH | 9/14/2022 | $471 |
|
